FIELD: medicinal microbiology. SUBSTANCE: anthrax strain STI-PR-4 is resistant to the modern agents of emergency prophylaxis, namely to doxycyclin, pefloxacin, rifampicin, ampicillin, nalidixic acid, and shows identical values of immunogenicity with the strain STI-1 which is the parent strain. Invention can be used for constructing vaccine preparations exhibiting resistance to antibiotics and used for prophylaxis of anthrax infection on the background of antibiotic therapy. EFFECT: enhanced resistance of strain. 6 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR COMPLEX PROPHYLAXIS OF ANTHRAX | 2002 |
|
RU2216349C1 |
METHOD TO OBTAIN DRY COMBINED ANTHRAX VACCINE | 1999 |
|
RU2181294C2 |
TEST-INFECTING CULTURE IN ASSAY OF IMMUNOGENICITY OF ANTHRAX VACCINES, EFFECTIVENESS OF AGENTS FOR EMERGENCY PROPHYLAXIS AND TREATMENT OF PATIENTS WITH ANTHRAX | 1997 |
|
RU2141522C1 |
MIXED ANTHRAX VACCINE | 1992 |
|
RU2115433C1 |
METHOD OF MAINTENANCE OF ANTHRAX VACCINE STRAIN STI-1 | 1997 |
|
RU2142009C1 |
METHOD FOR TREATING GENERALIZED FORM OF ANTHRAX INFECTION | 2002 |
|
RU2214834C1 |
AGENT OF BACTERICIDE ACTION IN RELATES TO VEGETATIVE AND SPORE CELLS Bacillus anthracis, METHOD FOR MALIGNANT ANTHRAX PROPHYLAXIS AND TREATMENT | 2005 |
|
RU2296576C2 |
ATTENUATED STRAIN Bacillus anthracis FOR DEVELOPING MEANS OF SPECIFIC PREVENTION OF ANTHRAX | 2013 |
|
RU2544951C1 |
METHOD OF PREPARING PREPARATIONS FOR CYTOREFRACTOMETRIC ASSAY OF GLANDERS MICROORGANISMS | 1998 |
|
RU2149899C1 |
VACCINE AGAINST PORCINE SALMONELLOSIS | 2003 |
|
RU2255763C2 |
Authors
Dates
2001-09-10—Published
2000-01-19—Filed